Legal Opinion
Amgen Inc. v. Price
District Court, District of Columbia
Decided January 26, 2018No. Civil Action No. 2017-1006Published
1Opinion of the Court
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA AMGEN INC., Plaintiff, v. ERIC D. HARGAN, Acting Secretary, Department of Health and Human Services, et al., Civil Action No. 17-1006 (RDM) Defendants, and TEVA PHARMACEUTICALS USA, INC., et al., Intervenor-Defendants. MEMORANDUM OPINION AND ORDER To encourage pharmaceutical companies to study the safety and effectiveness of pediatric uses of drugs approved for adults, the Federal Food, Drug, and Cosmetic Act (“FFDCA”) grants six months of “pediatric exclusivity” to the sponsor of a brand-name drug if the sponsor conducts studies that…
2Cases cited59 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Citizens to Preserve Overton Park, Inc. v. VolpeSupreme Court of the United States · 1971
- United States v. Mead Corp.Supreme Court of the United States · 2001
- Marsh v. Oregon Natural Resources CouncilSupreme Court of the United States · 1989
54 more not listed; retrieve them via the Exa API.